CanSino Biologics' (HKG:6185, SHA:688185) ACYW135 Meningococcal Polysaccharide Conjugate Vaccine received a drug registration certificate from the Administración Nacional de Medicamentos, Alimentos y Tecnología Médica.
The product is used for the prevention of epidemic cerebrospinal meningitis associated with ACYW135 Neisseria meningitidis, according to a Thursday Hong Kong bourse filing.